Seres Therapeutics Inc (NAS:MCRB) Stock News, Headlines & Updates
Seres Therapeutics Inc Stock News from GuruFocus
- 1
Aug 14, 2024
Seres Therapeutics Inc (MCRB) Q2 2024 Earnings Call Transcript Highlights: Strong VOWST Sales Growth and Strategic Asset Sale
GuruFocus Research • 1:03am
Q2 2024 Seres Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:04pm
Aug 13, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCRB, PALT, MRO on Behalf of Shareholders
PRNewswire • 6:00pm
Seres Therapeutics Inc (MCRB) Q2 2024 Earnings: GAAP EPS of -$0.22 Beats Estimate, Revenue Soars to $126.5 Million
GuruFocus Research • 6:34am
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
Marketwired • 6:00am
Aug 09, 2024
MCRB Investigation Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Seres Therapeutics, Inc. Assets Is Fair to Shareholders
Business Wire • 10:00am
Aug 06, 2024
Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
Marketwired • 6:00am
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
Marketwired • 6:00am
Jun 07, 2024
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 3:00pm
Jun 06, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news